Synthetic Stem Cells Market Analysis, Geographical Segmentation, Drivers, Challenges, Trends Forecasts Report

The study involved four major activities in estimating the current market size for synthetic stem cells. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Secondary Research:

In the secondary research process, various secondary sources such as Hoovers, Bloomberg Business Week, Forbes, and Dun & Bradstreet were referred to, to identify and collect information useful for this technical, market-oriented, and commercial study of the synthetic stem cells industry. These secondary sources included annual reports, press releases & investor presentations of companies; white papers; certified publications; articles by recognized authors; gold standard & silver standard websites; food safety organizations; regulatory bodies; trade directories; and databases. Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, market classification, and segmentation, according to the industry trends to the bottom-most level and regional markets.

According to the new market research report “Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada), Europe, APAC, RoW) – Global Forecast to 2028″ published by MarketsandMarkets™, the artificial stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=4959435

Geographically; North America is estimated to account for the largest share of the market in 2023. North America is the pioneer of synthetic stem cell technology. Also, North America leads in the R&D of stem cell therapies globally, with the registration of the highest number of clinical trials (more than 1400) on stem cells till 2018. This is further backed by the high rate of adoption of advanced therapies in the US (more than 600 stem cell therapy clinics in the US in 2016).

The key developers of synthetic stem cell technology are North Carolina State University (NCSU) (US) and Zhengzhou University (China).

Market Size Estimation;

The top-down approach was used to estimate and validate the total size of the synthetic stem cells market. The approach was also used extensively to estimate the size of various sub-segments in the market. The research methodology used to estimate the market size includes the following:

– Synthetic stem cells that could be used as therapy were identified through secondary research, and their market shares in the respective segments were determined through primary and secondary research.

– The procedure included extensive interviews with industry leaders such as CEOs, VPs, directors, and marketing executives for key insights.

– All percentage shares, splits, and breakdowns were determined using secondary sources and are verified through primary sources.

– All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4959435

The cardiovascular diseases segment accounted for the largest share during the forecast period.

The major applications of synthetic stem cells include cardiovascular diseases, neurological disorders, and other diseases that require regenerative therapy. Cardiovascular diseases have high prevalence across the globe. Currently, synthetic mesenchymal cells have been developed only for cardiac tissue and have been tested in mice models. The research on cardiac synthetic stem cells is expected to enter the clinical phase in the coming 2-3 years, and the first commercial product would be cardiac synthetic stem cells in the next five years.

Veterinary X-ray Market Size, Share, Outlook, Industry Analysis Report 2018

The study involved four major activities to estimate the current market size for veterinary X-ray products. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, trade directories, and databases such as D&B Hoovers and Bloomberg Businessweek were referred to identify and collect information for this study.

According to the new market research report “Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) – Forecast” published by MarketsandMarkets™, is projected to reach USD 872 million by 2023 from USD 640 million in 2018, at a CAGR of 6.4%.

Recent Developments:

– In 2018, Heska Corporation (US) formed a partnership with Pathway Vet Alliance (US). Under the terms of this agreement, Pathway plans to align its internal diagnostic portfolio with Heska, which can provide in-house operational services like point-of-care blood diagnostics, digital imaging, and allergy testing.

– In 2018, Carestream Health signed a service partnership agreement with Med Imaging Healthcare, a Diagnostic Imaging equipment maintenance company. The partnership was aimed at providing wider maintenance coverage and support for Carestream customers across Scotland.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=126397675

Geographically; North America accounted for the largest share of the veterinary X-ray market in 2017, followed by Europe and the Asia Pacific. Rising number of veterinary practices, increasing number of companion animals, and rising companion animal healthcare expenditure are some of the key factors driving the growth of the animal x-ray market in North America.

The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126397675

Market Segmentation in Detailed:

“Computed Radiography Systems Accounted for the Largest Market Share”

On the basis of technology, the veterinary X-ray market is segmented into direct radiography (DR), computed radiography (CR), and film-based radiography systems. The computed radiography systems segment accounted for the largest share of the animal X-ray market in 2017. Benefits offered by CR systems over traditional X-ray systems, resulting in a large-scale replacement of traditional film X-ray systems, is the major factor responsible for the large share of this segment.

“Small Companion Animals Segment Held the Largest Share of the Veterinary X-ray Market”

Based on the type of animal, the X-ray market is segmented into small companion animals and large animals. The small companion animals segment accounted for the largest share of the animal X-ray market in 2017. The large share of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, growing demand for pet insurance, and technological advancements in imaging modalities for small companion animals.

Microservices in Healthcare Market - Global Industry Analysis,Share, Trends, Status and Future Forecast

The benefits of microservice architecture, such as their ability to increase overall efficiency and project delivery speed, are the primary factor driving the market growth. However, concerns regarding security and regulatory compliance and the complexity of architecture are expected to hinder the growth of this market.

According to the new market research report “Microservices in Healthcare Market by Component (Platform, Services (Consulting, Integration, Training, Support, Maintenance)), Delivery (Cloud, Hybrid, Private, On-premise), End User (Health care Provider, Payer, Life Science) – Global Forecast” published by MarketsandMarkets™, is projected to reach USD 343.3 million by 2023 from the estimated USD 103.1 million in 2017, at a CAGR of 21.3%.

The Objectives of this study are as follows:

– To define, describe, and forecast the global microservices in healthcare market by deployment model, component, end user, and region

– To provide detailed information about the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

– To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

– To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=119908608

Geographically; North America is estimated to command the largest share of the market. The large share of North America in the global microservices in healthcare market can be attributed to the growing focus on improving the overall efficiency of healthcare organizations and greater product and service availability in the region.

The microservices in healthcare market is marked by the presence of several big and small players. Prominent players in this market include AWS (US), CA Technologies (US), Microsoft (US), Salesforce (US), Pivotal Software (US), Infosys (India), IBM (US), NGINX (US), Oracle Corporation (US), and Syntel (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119908608

Market Segmentation in Detailed:

The platform segment is expected to dominate the microservices in healthcare market in 2018.

Based on component, segmented into platforms and services. The services segment is further segmented into consulting services, integration services, and training, support, and maintenance services. The platforms segment is expected to account for the larger share of the microservices in healthcare market in 2018. This is attributed to the increasing need for cloud microservice architecture for scaling functions at a very granular level for efficient system optimization and organization. Cloud platform microservice architecture also brings a new level of scalability to enterprise applications.

The healthcare providers segment is expected to dominate the market in 2018.

Based on end user, the microservices in healthcare market is segmented into healthcare payers, healthcare providers, life science organizations, and clinical laboratories. The healthcare providers segment is expected to account for the largest share of the overall market in 2018. Government initiatives that help providers gain incentives on the adoption of EHRs and the implementation of integration and connectivity solutions are driving the adoption of microservices architecture solutions among healthcare providers.

Urgent Care Apps Market Size, Opportunities for Revenue Growth, and Future Forecast

The growth of Urgent Care Apps Market is influenced by a number of factors, such as the increasing penetration of smartphones, growing penetration of 3G and 4G networks, rising focus on patient-centric healthcare delivery, and the benefits offered by urgent care apps. However, the wide usage of consumer instant messaging apps, poor internet connectivity in several countries, and the high volume of miscategorized apps on Android and Apple stores are the major factors that are expected to restrain the growth of this market during the forecast period.

According to the new market research report “Urgent Care Apps Market by Type (Emergency Care Triage Apps, In-hospital Communication Apps, Post-hospital Apps (Nurse Communication Apps, Rehab Apps, Medication Management Apps)), Clinical Area (Stroke, Trauma, STEMI) – Global Forecast” published by MarketsandMarkets™, is expected to reach USD 2,515.1 million, at a CAGR of 41.3% during the forecast period.

Objectives of the Study:

• To define, describe, segment, and forecast the global urgent care apps industry by type, clinical area, and region.
• To forecast the size of the urgent care apps market in North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa.
• To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=45792223

Geographically; North America is expected to hold the largest share of the urgent care apps market in 2018, followed by Europe. The growth of the North American apps market is driven by the implementation of regulations in the region regarding the safety of patient data and improving quality of care, increasing penetration of 4G networks, rising need to reduce the escalating healthcare costs, and the rising focus on patient-centric healthcare delivery.

Some of the prominent players in urgent care apps market are Allm (Japan), Pulsara (US), Vocera Communications (US), PatientSafe Solutions (US), Voalte (US), Twiage (US), TigerConnect (US), Imprivata (US), Siilo (Netherlands), Forward Health (UK), Hospify (UK), Argusoft (US), Alayacare (US), Pivot Design Group (Canada), Medisafe (US), Smartpatient (Germany), and Johnson & Johnson (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45792223

Market Segmentation in Detailed:

The post-hospital apps segment held the largest share of the market in 2018.

On the basis of type, the urgent care apps market is segmented into pre-hospital emergency care & triaging apps, in-hospital communication & collaboration apps, and post-hospital apps. In 2017, the post-hospital apps segment accounted for the largest share of the apps market. With growing concerns about medication noncompliance and medication dosage errors, the adoption of medication management apps is on the rise. Better connectivity and networks have enhanced the outcome of such apps, which is further boosting the adoption of these apps by patients and healthcare professionals.

In 2018, the trauma segment is expected to account for the largest share of the market.

Based on clinical area, the global urgent care apps market is broadly segmented into trauma, stroke, cardiac conditions, and other clinical areas. In 2018, the trauma segment is slated to account for the largest share of the market. The increasing number of road accident across the globe is driving the growth of this segment. As the awareness to address trauma is increasing due to continuous efforts by health organizations, such as WHO, the adoption of apps to manage trauma and casualty among paramedics and emergency centers is also growing.

Ureteroscopy Market 2021 - by Global In-depth Analysis, Regional Outlook, Latest Trend and Forecast

The high incidence of urolithiasis across the globe is a major factor driving the growth of Ureteroscopy Market. The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the flexible ureteroscopy market in the coming years.

According to the new market research report “Flexible and Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) – Global Forecast” published by MarketsandMarkets™, the global semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million, at a CAGR of 5.4%

The Objectives of this Study are as follows:

• To define, describe, and forecast the flexible & semi-rigid ureteroscopy market by product type, application, end user, and region
• To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
• To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market
• To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=253934795

Geographically; the flexible and semi-rigid ureteroscopy market is geographically classified into North America, Europe, Asia, and the Rest of the World (RoW). North America is the largest regional market for ureteroscopes majorly due to the high prevalence of kidney stones (and the large number of surgical procedures performed for the same) and the rising healthcare expenditure in this region. Asia is expected to grow at the highest CAGR in the flexible ureteroscopy market during the forecast period. Growth in this region is mainly due to the large patient population.

Some of the major players operating in ureteroscopy market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253934795

Market Segmentation in Detailed:

Flexible ureteroscopes are expected to account for the largest share of the market in 2018

By type of product, the flexible & semi-rigid ureteroscopes market is further segmented into flexible and semi-rigid ureteroscopes. The flexible ureteroscopes segment is expected to account for the largest share in 2018. The growing incidence of urolithiasis, rising prevalence rate of kidney cancers, and technological advancements in flexible ureteroscopes are the primary factors driving the growth of the ureteroscopy market. The flexible ureteroscopes market is further segmented into fiberoptic and digital ureteroscopes. The digital ureteroscopes segment is expected to account for the larger market share in 2018 owing to the higher efficacy and better image output of these devices.

Hospitals are expected to dominate the flexible and semi-rigid ureteroscopy end-user market in 2018

By end user, the flexible and semi-rigid ureteroscopy market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment is expected to account for the largest share of the flexible ureteroscopy market. This large share can be attributed to the high number of surgeries performed in hospitals.

Medical Vacuum System Market Research Report 2019-2024 By Key players and Growth Rate

The Factors such technological advancements in vacuum systems, stringent regulatory frameworks mandating the use of vacuum systems, the increasing number of target surgical procedures across major markets, and the rising number of Diagnostic Imaging procedures are driving the growth of the global medical vacuum systems market.

According to the new market research report “Medical Vacuum System Market by Product (Standalone, Centralized, Portable), Technology (Dry Claw, Oil Sealed Rotary Vane, Liquid Ring), Application (Diagnostic, Wound Care, GYN), End user (Pharmaceutical, Diagnostic Labs) – Global Forecast to 2024″ published by MarketsandMarkets™, is estimated to grow at a CAGR of 6.3% to reach USD 1.6 billion.

Recent Developments:

-> In November 2018, Busch LLC (Germany) and Pfeiffer Vacuum Technology AG (Germany) entered into a strategic cooperation agreement in order to enhance segments such as sales & services, R&D developments, and improve the vacuum product line.

-> In October 2018, ConvaTec (UK) received the US FDA 510(k) Clearance for its Avelle Negative Pressure Wound Therapy System.

-> In March 2018, Atlas Copco AB (Sweden) acquired Walker Filtration for USD 38.68 million for enhancing its vacuum business

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=150008017

Geographically; North America accounted for the largest share of the medical vacuum systems market in 2018. The dominant position of this region in the medical vacuum systems industry is due to technology advancements; cleanroom mandates, manufacturing guidelines, and surgical protocols; increased number of target medical procedures and trauma cases; a growing number of end users; the rising number of diagnostic imaging procedures; and rising expenditure healthcare infrastructure in the country.

Atlas Copco AB (Sweden), Gardner Denver Holdings (US), Busch Holding GmbH (Germany), Drägerwerk AG & Co. KGaA (Germany), Asahi Kasei ZOLL Medical Corporation (Japan), Olympus Corporation (Japan), ConvaTec (UK), INTEGRA Holdings (US), Allied Healthcare Products Inc. (US), Medela AG (Switzerland), Air Techniques (US), Laerdal Medical (Norway), Precision Medical, Inc. (US), Medicop (Slovenia), and Ohio Medical Corporation (US) are some major players in the global medical vacuum systems market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150008017

Market Segmentation in Detailed:

The standalone vacuum systems segment is expected to account for the largest share of the medical vacuum systems market.

On the basis of product type, segmented into standalone vacuum systems, centralized vacuum systems, portable vacuum systems, and accessories. The standalone vacuum systems segment accounted for the largest share of the medical vacuum systems market in 2018. The large share of this segment can be attributed to the large end-user base for compact/standalone products, their technical advantages, and significant adoption among dental clinics and research labs.

The therapeutic applications segment is expected to register the highest growth rate in the vacuum systems market.

On the basis of application, the medical vacuum systems market is segmented into pharma-biotech manufacturing, therapeutic applications, diagnostic applications, and research applications. Therapeutic applications are further segmented into dental, wound care, anesthesiology, and gynecology applications. The therapeutic applications segment is expected to register the highest growth rate due to the rising incidence of dental caries and other periodontal diseases, increasing use of NPWT for diabetic ulcers, and the increasing number of target medical procedures across major markets.

Medical Device Security Market - Growth by Top Key Players, Application and Forecast Analysis

The Factors such as increasing instances of healthcare cyber-attacks and threats, growing geriatric population and the subsequent growth in chronic disease management, government regulations and need for compliance, growing demand for connected medical devices, and increasing adoption of BYOD and IoT are driving the growth of the device security market.

According to the new market research report “Medical Device Security Market by Solution (Encryption, Antivirus, Identity & Acess Management), Services (Professional, Managed), Type (Network Security, Endpoint Security), Device Type, End User (Healthcare Provider) – Global Forecast” published by MarketsandMarkets™, is projected to reach USD 6.59 Billion by 2023, at a CAGR of 8.6% during the forecast period.

Objectives of the study:

• To define, describe, and forecast the global medical device security market by component (solution and services), type, device type, end user, and region
• To provide detailed information about factors affecting the growth of the market (drivers, restraints, opportunities, and challenges)
• To analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To profile key players in this market and comprehensively analyze their market shares and core competencies

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=70612561

Geographically; the Medical Device Security Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to dominate the market followed by Europe. The market in North America is primarily driven by increasing instances of cyberattacks on medical devices, growing adoption of connected medical devices, increasing awareness among healthcare professionals regarding cybersecurity, and government initiatives to implement security solutions are driving the market in region.

The prominent players in the global medical device security market include Cisco Systems (US), IBM Inc. (US), GE Healthcare (US), Symantec Inc.(US), CA Technologies (US), Philips (Netherlands), DXC Technology (US), CloudPassage (US), FireEye (US), Check Point Software Technologies (Israel), Sophos (UK), Imperva (US), Fortinet (US), Palo Alto Networks (US), ClearDATA (US), and Zscaler (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=70612561

Market Segmentation in Detailed:

The endpoint security segment is estimated to have the largest share of the market in 2018.

Based on type, the medical device security market is broadly divided into application security, endpoint security, network security, cloud security, and other security types (email, web, and database security). The endpoint security segment is expected to dominate the market in 2018. The large share of this segment is attributed due to the increasing number of connected medical devices, networks are becoming more vulnerable to new and sophisticated threats such as zero-day malware, trojans, and APTs. Additionally, the trend of bring your own device (BYOD), social media usage, and cloud synchronizing tools are also driving the demand for endpoint security.

The wearable and external medical devices are expected to witness the highest growth during the forecast period.

Based on device type, the medical device security market is segmented into hospital medical devices, internally embedded medical devices, and wearable and external medical devices. The wearable and external medical devices segment is expected to register the highest CAGR during the forecast period. This growth is attributed to the demand for home healthcare owing to the high and rising prevalence of chronic diseases and the growing need to reduce healthcare costs. These factors are increasing the demand and uptake of wearable and external medical devices for remote patient monitoring.

Bronchoscopy Market - Segmentation, Major Players & Geographical Analysis

The growth of Bronchoscopy Market is primarily driven by the growing hospital investments in bronchoscopy facilities, rising demand for bronchoscopy owing to the rising prevalence of respiratory diseases, the growing demand for minimally invasive surgery, and technological advancements in bronchoscopy. However, the dearth of trained physicians and pulmonologists is the major challenge for the growth of this Bronchoscopy Equipment Market.

According to the new market research report “Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Monitor, Camera), Accessories, Working Channel Diameter (2.8, 2.2, 3.0), Usability (Reusable, Disposable), & End Users (Hospital, ACSs/Clinic) – Global Forecast to 2024” published by MarketsandMarkets™, the Bronchoscopy Equipment Market is projected to reach USD 2.6 billion by 2024 from an estimated USD 2.0 billion in 2019 at a CAGR of 5.9% during the forecast period.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=40057877

Geographically; North America dominated the bronchoscopy equipment market in 2018. The large share of North America in the global bronchoscopy market is attributed to the increase in the incidence and prevalence of chronic respiratory diseases, favorable reimbursement scenario in the US, and rising incidence of lung cancer in Canada.

The Asia Pacific market, on the other hand, is projected to register the highest growth during the forecast period. Factors such as the increasing number of hospitals, developing healthcare infrastructure, increasing healthcare expenditure, rising geriatric population, and the presence of a large patient population are driving the growth of the Bronchoscopes market in the Asia Pacific.

The key players in the global bronchoscopy market are Olympus Corporation (Japan), KARL STORZ (Germany), and FUJIFILM Holdings Corporation (Japan). Other prominent players in the market include Ambu A/S (Denmark), Boston Scientific (US), Ethicon (US), Medtronic (Ireland), HOYA Corporation (Japan), Richard Wolf GmbH (Germany), Cook Medical (US), CONMED Corporation (US), Roper Technologies (US), Teleflex Incorporated (US)

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40057877

Market Segmentation in Detailed:

The bronchoscopes segment accounted for the largest share of the market in 2018.

Based on product, segmented into bronchoscopes, imaging systems, accessories, and other bronchoscopy equipment. The bronchoscopes segment accounted for the largest share of the bronchoscopy market in 2018. The large share of this segment can be attributed to the high cost of bronchoscopes compared to the imaging systems and accessories, increasing prevalence of lung cancer, and technological advancements.

Hospitals accounted for the largest market share in 2018.

Based on end user, segmented into hospitals and ambulatory surgery centers/clinics. The hospitals segment accounted for the largest share of the bronchoscopy market in 2018. The large share of this segment can be attributed to the high patient preference for hospital treatment, availability of skilled healthcare professionals, and favorable reimbursement scenario.